Why Fertility Preservation Matters
Cancer survival rates have improved dramatically. Today, many cancer patients — particularly young adults — will survive their disease and go on to desire families. However, many cancer treatments (chemotherapy, radiation, surgery) can permanently damage reproductive function.
Fertility preservation before cancer treatment offers patients the possibility of biological parenthood after recovery. At PTA Fertility Centre, we prioritise oncology referrals and can often initiate treatment within days of first contact.
Which Treatments Affect Fertility?
High Risk (>80% chance of permanent infertility)
- Alkylating agents: Cyclophosphamide (high dose), Busulfan, Melphalan
- Total body irradiation
- Pelvic radiation (ovarian dose >6 Gy in adults)
- Bilateral oophorectomy or orchiectomy
Moderate Risk (40-60%)
- Cyclophosphamide (standard dose)
- Cisplatin/Carboplatin combinations
- Doxorubicin/Adriamycin protocols
- Abdominal/pelvic radiation (lower doses)
Lower Risk (<20%)
- Methotrexate, 5-FU, Vincristine
- Taxanes (Paclitaxel, Docetaxel)
- Targeted therapies (Herceptin, Tamoxifen)
Important: Risk is cumulative and influenced by patient age, baseline ovarian reserve, and total drug dose. Younger patients are more resilient but not immune to damage.
Fertility Preservation Options for Women
Egg (Oocyte) Freezing
The most established method. Ovarian stimulation (10-14 days) followed by egg retrieval and vitrification. Requires approximately 2 weeks from start to completion.
- Timing: Can start at any point in the menstrual cycle (random-start protocols available for urgent cases)
- Delay to cancer treatment: Approximately 2 weeks
- Success: Survival rate >90% upon thawing; future pregnancy rates depend on age at freezing and number of eggs stored
- Suitable for: Post-pubertal women, no partner required
Embryo Freezing
Same as egg freezing but eggs are fertilised with partner/donor sperm before freezing. Slightly higher success rates than egg freezing as embryos are more robust.
- Requirements: Partner or donor sperm
- Advantage: Proven technology with decades of data
- Consideration: Shared ownership of embryos (relevant if relationship status changes)
Ovarian Tissue Freezing
Surgical removal and freezing of ovarian cortex tissue containing primordial follicles. The tissue can later be transplanted back to restore both fertility and hormonal function.
- Advantage: No delay to cancer treatment (surgery can often be combined with port insertion); suitable for pre-pubertal girls
- Status: No longer considered experimental; live births reported worldwide
- Limitation: Requires surgery; theoretical risk of re-introducing cancer cells (for blood cancers)
GnRH Agonist (Ovarian Suppression)
Monthly injections (Lucrin/Zoladex) during chemotherapy to suppress ovarian function, potentially protecting follicles from damage.
- Evidence: Some evidence of benefit, particularly for breast cancer patients
- Limitation: Not a substitute for egg/embryo freezing — should be used as an adjunct, not sole strategy
Fertility Preservation for Men
Sperm Freezing (Cryopreservation)
Simple, non-invasive, and can be done in a single visit. Multiple samples can be stored for increased security.
- Timing: Ideally before any chemotherapy (even one cycle can damage sperm DNA)
- Process: Semen sample collected by masturbation, processed, and frozen
- Delay: None — can be done the same day as oncology consultation
- Success: Frozen sperm can be used for IUI or IVF/ICSI with good outcomes
Testicular Sperm Extraction (TESE)
For men unable to ejaculate or with very low sperm counts due to disease, surgical extraction from testicular tissue is possible.
Timing and Urgency
The window between cancer diagnosis and treatment start is often narrow. Key principles:
- For men: Sperm can be frozen the same day — no delay to cancer treatment
- For women: Egg freezing requires ~2 weeks. Random-start protocols allow treatment to begin at any cycle day, minimising delay
- Oncology coordination: Most oncologists support a 2-week delay for fertility preservation when safe. We communicate directly with your oncology team
- Urgent referral pathway: At PTA Fertility Centre, oncology fertility referrals are seen within 24-48 hours. Call +27 12 998 8854 and inform reception that this is an oncology fertility preservation referral
For Referring Oncologists
We welcome referrals from oncology teams across South Africa. Our oncofertility pathway includes:
- Same-day or next-day consultation for urgent cases
- Direct communication with the treating oncology team
- Random-start stimulation protocols to minimise delay
- GnRH antagonist protocols safe for hormone-sensitive cancers
- Letrozole co-treatment for breast cancer patients requiring stimulation
- Coordination with surgical teams for ovarian tissue cryopreservation
Referral contact: +27 12 998 8854 | info@ptafertility.co.za (mark as "Oncofertility — Urgent")
